Errors in the treatment of highly differentiated thyroid cancer as a multidisciplinary problem

Errors in the treatment of highly differentiated thyroid cancer as a multidisciplinary problem

Highly diﬀerentiated thyroid cancer is a common endocrine neoplasm with a favorable prognosis. However, errors in the treatment of this pathology can signiﬁcantly worsen the patient’s quality of life.Patient V., 65 years old, underwent an operation for papillary thyroid cancer with an injury to the...

Full description

Bibliographic Details
Main Authors:	N. I. Volkova, M. D. Merenkova
Format:	Article
Language:	English
Published:	State Budget Educational Institute of Higher Professional Education, Rostov State Medical University, Ministry Health of Russian Federation 2021-07-01
Series:	Медицинский вестник Юга России
Subjects:	thyroid cancer radioiodine therapy thyroidectomy metastases complications
Online Access:	https://www.medicalherald.ru/jour/article/view/1361

Similar Items

Radioiodine-resistant metastases of well-differentiated thyroid cancer, analysis of tumor characteristics and primary surgical intervention
by: M. V. Ostafiychuk, et al.
Published: (2021-10-01)

Retrospective Analysis of the Development of Human Thyroglobulin during Pregnancy in Patients with Treated Non-Recurrent Differentiated Thyroid Cancer
by: Justus Baumgarten, et al.
Published: (2022-05-01)

Pre-ablative Diagnostic Whole-body Scan Following Total Thyroidectomy for Well-differentiated Thyroid Cancer: Is It Necessary?
by: Choon Meng Teoh, et al.
Published: (2005-04-01)

Myxedema Psychosis after Levothyroxine Withdrawal in Radioactive Iodine Treatment of Differentiated Thyroid Cancer: A Case Report
by: Nutnicha Pattaravimonporn, et al.
Published: (2021-11-01)

Case report<Br>Graves’ thyrotoxicosis in a patient with metastatic differentiated thyroid carcinoma and chronic lymphocytic leukaemia (CLL)
by: Jacek Makarewicz, et al.
Published: (2007-06-01)

The association between the interval of radioiodine treatment and treatment response, and side effects in patients with lung metastases from differentiated thyroid cancer
by: Hongxi Wang, et al.
Published: (2023-05-01)

Cost-effectiveness profile, organizational implications and patient preferences on the use of exogenous TSH therapy (Thyrogen®) vs. THW in thyroid residue ablation in Italy
by: Gianluca De Danieli, et al.
Published: (2016-10-01)

Association of the Cumulative Dose of Radioactive Iodine Therapy With Overall Survival in Patients With Differentiated Thyroid Cancer and Pulmonary Metastases
by: Jing Yang, et al.
Published: (2019-06-01)

Sudden Development of Subcutaneous Nodules Shortly after Radioiodine Treatment for Thyroid Cancer Caused by Self-Limiting Sarcoidosis
by: Wael Zaher, et al.
Published: (2020-05-01)

Radioiodine Refractory Follicular Thyroid Cancer and Surgery for Cervical Relapse
by: Costanza Chiapponi, et al.
Published: (2021-12-01)

Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice
by: Jaume Capdevila, et al.
Published: (2023-08-01)

Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer – a prospective comparison of long-term outcomes
by: Aleksandra Kukulska, et al.
Published: (2020-08-01)

Impact of different approaches to calculation of treatment activities on achieved doses in radioiodine therapy of benign thyroid diseases
by: Jochen Hammes, et al.
Published: (2018-12-01)

Long-Term Outcomes and Prognoses of Elderly Patients (≥65-Years-Old) With Distant Metastases From Well-Differentiated Thyroid Cancer During Radioiodine Therapy and Follow-Up
by: Zhong-Ling Qiu, et al.
Published: (2021-02-01)

Do Molecular Profiles of Primary Versus Metastatic Radioiodine Refractory Differentiated Thyroid Cancer Differ?
by: Cristiane J. Gomes-Lima, et al.
Published: (2021-02-01)

Comparison of 1.1 GBq and 2.2 GBq Activities in Patients with Low-Risk Differentiated Thyroid Cancer Requiring Postoperative <sup>131</sup>I Administration: A Real Life Study
by: Alfredo Campennì, et al.
Published: (2023-04-01)

Recombinant human TSH versus thyroid hormone withdrawal in adjuvant therapy with radioactive iodine of patients with papillary thyroid carcinoma and clinically apparent lymph node metastases not limited to the central compartment (cN1b)
by: Pedro Weslley Rosario, et al.
Published: (2017-02-01)

Effect of COVID-19 pandemic on diagnosis and treatment of thyroid cancer in Brazil
by: Vitor Bock Silveira, et al.
Published: (2022-10-01)

Combined and complex treatment of high-differential local-distributed cancer of the thyroid gland
by: I.V. Deineko, et al.
Published: (2019-12-01)

Thyroid carcinoma in woman. gynecologist view
by: Т. Ф. Татарчук, et al.
Published: (2019-06-01)

Overview of Thyroid Surgery Complications
by: Juraj Lukinović, et al.
Published: (2020-01-01)

Multidisciplinary approach for risk-oriented treatment of low-risk papillary thyroid cancer in Switzerland
by: Henryk Zulewski, et al.
Published: (2019-01-01)

Use of multikinase inhibitors/lenvatinib concomitant with antiresorptive therapy for bone metastases from radioiodine‐resistant differentiated thyroid cancer
by: Elena Navarro‐Gonzalez
Published: (2022-10-01)

Recurrent Differentiated Thyroid Cancer: The Current Treatment Options
by: Andrés Coca-Pelaz, et al.
Published: (2023-05-01)

Radionuklidna terapija bolesnika sa regionalnim i udaljenim metastazama diferenciranog karcinoma štitaste žlezde
by: Mihailović Jasna
Published: (2011-01-01)

Restaging of differentiated thyroid carcinoma with SPECT/CT after radioiodine therapy
by: Mariya Alekseevna Karalkina, et al.
Published: (2015-07-01)

Temporal Evolution and Prognostic Role of Indeterminate Response Sub-Groups in Patients with Differentiated Thyroid Cancer after Initial Therapy with Radioiodine
by: Domenico Albano, et al.
Published: (2023-02-01)

Occurrence of symptomatic meningioma as a second neoplasm in patients with differentiated thyroid cancer treated with radioiodine
by: Nishikant Avinash Damle, et al.
Published: (2012-01-01)

A rare case of laryngotracheal chondrosarcoma in a patient with past history of radioiodine therapy for thyroid cancer
by: Gholamreza Mohajeri, et al.
Published: (2013-01-01)

The effect of radioactive iodine treatment for differentiated thyroid cancer on male gonadal function: a meta-analysis
by: Yanling Cai, et al.
Published: (2023-11-01)

Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer
by: Massimiliano Pacilio, et al.
Published: (2022-07-01)

Development and validation of nomograms for predicting survival in differentiated thyroid cancer patients with or without radioiodine therapy
by: Bingyu Ran, et al.
Published: (2023-03-01)

Non-thyroidal second primary malignancy in papillary thyroid cancer patients
by: Diana Borges Duarte, et al.
Published: (2023-01-01)

Diagnosis and management of hurthle cell carcinoma, a rare case report
by: Marlinda Adham, et al.
Published: (2020-01-01)

Delayed Initial Radioiodine Adjuvant Therapy Does Affect Biochemical Response in Intermediate- to High-Risk Differentiated Thyroid Cancer
by: Feng Yu, et al.
Published: (2021-11-01)

A Mathematical Model of Thyroid Disease Response to Radiotherapy
by: Araceli Gago-Arias, et al.
Published: (2021-09-01)

APOPTOSIS ROLE IN FORMING RADIOIODINE RESISTANCE IN DIFFERENTIATED THYROID CANCER
by: K.A. GARIPOV, et al.
Published: (2020-06-01)

Strongly Radioiodine-Positive Pancreatic Adenocarcinoma Mimicking Metastasis of Differentiated Thyroid Cancer
by: Florian Rosar, et al.
Published: (2022-08-01)

Progress on Targeted Therapy of Radioiodine-refractory Differentiated Thyroid Cancer
by: TENG Lisong, et al.
Published: (2023-05-01)

Prognostic factors for postoperative papillary thyroid cancer with unexplained elevated Tg: A retrospective study
by: Chenghui Lu, et al.
Published: (2024-03-01)